Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "We had a buy call on Glenmark Pharma a few days ago because it was bottoming out after a sharp correction and that W shape bottom is getting confirmed today. It is a double bottom in simple language. It is a buying opportunity, forget what has happened today, this is just a beginning of a stunning rally."
On January 27, 2014 Glenmark Pharma closed at Rs 534.90, up Rs 25.85, or 5.08 percent.
The share touched its 52-week high Rs 612 and 52-week low Rs 458 on 12 July, 2013 and 28 March, 2013, respectively.
The company's trailing 12-month (TTM) EPS was at Rs 15.40 per share. (Dec, 2013). The stock's price-to-earnings (P/E) ratio was 34.73. The latest book value of the company is Rs 93.05 per share. At current value, the price-to-book value of the company was 5.75. The dividend yield of the company was 0.37 percent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
